BIOSPECIFICS TECHNOLOGIES CORP 4/A
4/A · BIOSPECIFICS TECHNOLOGIES CORP · Filed Feb 3, 2017
Insider Transaction Report
Form 4/AAmended
Wegman Thomas
DirectorPresident10% Owner
Transactions
- Sale
Common Stock, $.001 par value
2016-11-29$48.32/sh−8,945$432,188→ 292,549 total - Sale
Common Stock, $.001 par value
2016-11-28$48.04/sh−11,055$531,048→ 301,494 total
Footnotes (3)
- [F1]The selling price of $48.0369 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $47.50 to $49.40. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The selling price of $48.3161 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.25 to $48.77. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person and does not represent any acquisition or disposition of shares by the reporting person.